Article
The impact of Spike mutations on SARS-CoV-2 neutralization
2021-01-19
Abstract excerpt
Multiple SARS-CoV-2 vaccines have shown protective efficacy, which is most likely mediated by neutralizing antibodies recognizing the viral entry protein, Spike. Antibodies from SARS-CoV-2 infection neutralize the virus by focused targeting of Spike and there is limited serum cross-neutralization of the closely-related SARS-CoV. As new SARS-CoV-2 variants are rapidly emerging, exemplified by the B.1.1.7, 501Y.V2 a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 63f17b66-0a7c-56e2-b9ec-0ca72f83a05f
- DOI
- 10.1101/2021.01.15.426849
